AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2023
Aug 7, 2023
35475_dirs_2023-08-07_cf953ebc-e5fc-448d-9f89-c1e39cfc28c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2023-08-07
Reporting Person: Waltzman Roger J. (Chief Medical Officer)
More from Indaptus Therapeutics, Inc.
Board/Management Information
2026
Jun 5
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12